luzindole has been researched along with Neuroblastoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Niles, LP; Pan, Y | 1 |
| Govitrapong, P; Wongprayoon, P | 1 |
| Egea, J; García, AG; López, MG; Romero, A | 1 |
| Bujalance, I; Feijóo, M; Montilla, P; Muñoz, MC; Muñoz-Castañeda, JR; Túnez, I | 1 |
4 other study(ies) available for luzindole and Neuroblastoma
| Article | Year |
|---|---|
Epigenetic mechanisms of melatonin action in human SH-SY5Y neuroblastoma cells.
Topics: Acetylation; Cell Line, Tumor; Chromatin Assembly and Disassembly; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histones; Humans; Melatonin; Neuroblastoma; p300-CBP Transcription Factors; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Receptor, Melatonin, MT1; Signal Transduction; Tryptamines | 2015 |
Melatonin attenuates methamphetamine-induced neuroinflammation through the melatonin receptor in the SH-SY5Y cell line.
Topics: Antioxidants; Cell Line, Tumor; Central Nervous System Stimulants; Culture Media, Serum-Free; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Proteins; Inflammation; Melatonin; Methamphetamine; Neuroblastoma; Protein Transport; Receptors, Melatonin; RNA, Small Interfering; Time Factors; Transfection; Tryptamines; Tumor Necrosis Factor-alpha | 2015 |
Synergistic neuroprotective effect of combined low concentrations of galantamine and melatonin against oxidative stress in SH-SY5Y neuroblastoma cells.
Topics: Analysis of Variance; Cell Death; Cell Line, Tumor; Drug Synergism; Galantamine; Histocytochemistry; Humans; Mecamylamine; Melatonin; Neuroblastoma; Neuroprotective Agents; Oxidative Stress; Signal Transduction; Tryptamines | 2010 |
Effect of melatonin on the oxidative stress in N1E-115 cells is not mediated by mt1 receptors.
Topics: Animals; Cell Line, Tumor; Enzyme Inhibitors; Lipid Peroxidation; Melatonin; Mice; Neuroblastoma; Okadaic Acid; Oxidative Stress; Receptor, Melatonin, MT1; Tryptamines | 2003 |